News&Events

News&Events

2022.04.27
News
[Activity Report] Launch of New Website by AMED Public and Private Partnerships for Infectious Disease R&D (April 14, 2022) NEW
2022.04.25
News
[Activity Report] Himeji City becomes first municipality in Japan to issue declaration on the promotion of AMR countermeasures (February 21, 2022) NEW
2022.04.15
Event
[Registration Open] Japanese Society of Antimicrobials for Animals – The 48th Symposium (April 23, 2022)
2022.04.11
Event
[Registration Open] (Webinar) Making the ‘Silent Pandemic’ of AMR Heard: What Countries Leading the Charge Against AMR are Doing to Ensure their Populations are Protected (April 28, 2022)
2022.04.07
Event
[Event Report] WHO Regional Committee for the Western Pacific Related Event: “AMR: A Global Health Crisis” (September 25, 2021)
2022.03.31
News
[Case Study] Koji Masuda and Kenji Ikeda “TDM Is Not Only for Safety, but for Ensuring Effectiveness” (March 31, 2022)
2022.03.18
News
[Patient’s Voice] Ms. Sachiko Ito – Non-Tuberculosis Mycobacterial Lung Disease (March 18, 2022)
2022.03.17
Event
[Activity Report] Submission of recommendations to Public Comment on the “Interim Report of the Global Health Strategy in Japan Toward the 2030 Sustainable Development Goals (SDGs)” (March 17, 2022)
2022.03.07
News
[Case Study] Keisuke Kagami and Mitsuru Sugawara “Thrombocytopenia Can be Avoided By Monitoring Linezolid Blood Levels – Enabling Long-Term Linezolid Use for the Successful Treatment of Refractory Pyogenic Spondylodiscitis” (March 7, 2022)
2022.02.22
News
[Case Study] Keisuke Kagami and Mitsuru Sugawara “Concomitant piperacillin-tazobactam and vancomycin use increases the risk of acute kidney injury.” (AMR Alliance Japan, February 22, 2022)
2022.01.19
Event
[Event Report] Antimicrobial Resistance: A Future Global Health Crisis (January 13, 2022)
2022.01.14
News
[In the Media] “Faster Response to Antimicrobial Resistant Bacteria” (The Nikkei Personal Opinion and Insight, December 20, 2021)
2021.12.27
Event
[Event Report] The Third Meeting of Working Group 3 Under the Sub-committee on AMR of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) (December 17, 2021)
2021.12.23
Event
[Event Report] FY2022 AMR Alliance Japan Planning Meeting (December 6, 2021)
2021.12.22
News
[Case Study] Akari Shigemi “The importance of proper antimicrobial use for MRSA infections – Beware of rifampicin monotherapy induced resistance” (December 22, 2021)
2021.12.22
Event
[Registration Closed] (Webinar) Antimicrobial Resistance: A Future Global Health Crisis (January 13, 2022)
2021.12.02
News
[Publication Report] Incentivizing Resilience: Accelerating Efforts to Promote the Research and Development Needed to Save the World from the Next Pandemic (December 2, 2021)
2021.12.02
Event
[Event Report] Investing in the Future: The Role of Investors in Saving the World from AMR (September 8, 2021)
2021.11.26
News
[Research Report] Nearly 60% Would Pay More for New Antibiotics – Although knowledge of the threat of AMR remains low, new HGPI poll suggests that Japanese public would be willing to consider further financial support for new antibiotics (November 26, 2021)
2021.11.26
News
[Publication Report] Taking Action for AMR Preparedness: Spurring Antibiotic Innovation for Healthy Ageing in Super-Ageing Japan (November 18, 2021)

gotoTop